Nurse Practitioner, Adult Health · Boston, MA
NPI
1417427535
Since 2018
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
800 Washington St
Boston, MA, 02111
Phone (617) 636-6227
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
148 services
Medicare patients, 2024
78
Average age 69
Drug cost, 2024
$1.2M
195 prescriptions
Company payments, 2025
$374
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sean Feng was code 99214 (office e&m - established), 103 times for 62 patients. In total Sean Feng billed 148 services in 5 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 103 | 62 | $63.22 | $6,512 |
| 99215 Office E&M - Established | Facility | 38 | 29 | $100.01 | $3,800 |
By year: 2022 $5,096 for 69 services; 2023 $5,101 for 83 services; 2024 $11K for 148 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sean Feng prescribed most often to Medicare patients was Eliquis (Apixaban), with 51 prescriptions and refills. In total Sean Feng wrote 195 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 51 | 102 | 15 | $58K |
| Deferasirox Generic | 21 | 25 | Under 11 | $107K |
| Enoxaparin Sodium Generic | 14 | 14 | Under 11 | $1,095 |
| Mycophenolate Mofetil Generic | 12 | 12 | Under 11 | $542 |
| Jakafi Ruxolitinib Phosphate | 12 | 12 | Under 11 | $194K |
| Ferriprox (2 Times A Day) Deferiprone | 11 | 11 | Under 11 | $356K |
| Hydroxyurea Generic | 11 | 31 | Under 11 | $812 |
Brand drugs: 102 claims; generic drugs: 93 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sean Feng $374 ($374 in general payments such as food, travel and fees) from 13 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $66.82.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 2 | $66.82 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $35.56 |
| Agios Pharmaceuticals, Inc. AGIO | 1 | $32.39 |
| SpringWorks Therapeutics, Inc. | 1 | $30.93 |
| GlaxoSmithKline, LLC. GSK | 1 | $30.69 |
| Genentech USA, Inc. ROG.SW | 1 | $28.89 |
| Rigel Pharmaceuticals, Inc. RIGL | 1 | $26.91 |
| BeOne Medicines USA, Inc. ONC | 1 | $23.05 |
| Abbvie Inc. ABBV | 1 | $22.79 |
| Genmab U.S., Inc. GMAB | 1 | $21.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.